Gene · 55000
Papers3,031
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,031
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptomic Insights into lncRNA-miRNA-mRNA Networks Regulating Angiogenesis and Metastasis in Prostate Cancer. | BioTech (Basel) | 2026 | 41718350 | PubTator, text mining | PubMed |
| Lnc1267-hnRNP U interaction promotes radioresistance by inhibiting apoptosis via attenuated RelA/p65 Ser536 phosphorylation. | Cell Mol Life Sci | 2026 | 41703117 | PubTator, text mining | PubMed |
| Detecting Occult Sentinel Node Metastases in HNSCC: The Emerging Role of lncRNAs as Biomarkers and Future Perspectives for USgFNAB Molecular Profiling. | Cancers (Basel) | 2026 | 41681899 | PubTator, text mining | PubMed |
| Cellular Mechanisms and Therapeutic Targeting of Long Noncoding RNAs in Atherosclerotic Disease. | IUBMB Life | 2026 | 41681047 | PubTator, text mining | PubMed |
| MiR-499-5P/PACS2/TRPV1 Axis Maintains Mitochondrial Homeostasis and Left Ventricular Function after Extreme Cold Stress. | J Cardiovasc Transl Res | 2026 | 41644764 | PubTator, text mining | PubMed |
| Targeting PKC/NF-κB/NLRP3-driven NcRNA neuroinflammatory crosstalk by condensed tannins in global cerebral ischemia. | Inflammopharmacology | 2026 | 41615569 | PubTator, text mining | PubMed |
| Genetic polymorphism of long non-coding RNA TUG1 and susceptibility to polycystic ovary syndrome: a case-control study. | Hereditas | 2026 | 41566356 | PubTator, text mining | PubMed |
| Long non-coding RNAs and therapeutic resistance in multiple myeloma: from molecular insights to clinical applications. | Clin Exp Med | 2026 | 41547689 | PubTator, text mining | PubMed |
| LncRNA TUG1 promotes osteogenic differentiation of human umbilical cord mesenchymal stem cells by regulating miR-138/SIRT1 axis. | J Orthop Surg Res | 2026 | 41546042 | PubTator, text mining | PubMed |
| Seminal long non-coding RNAs as prognostic non-invasive biomarkers in non-obstructive azoospermia. | BMC Med Genomics | 2026 | 41530831 | PubTator, text mining | PubMed |
| Exploring the pleiotropic effects of lncRNA in different repeat expansion disorders. | Biochim Biophys Acta Mol Basis Dis | 2026 | 41130301 | PubTator, text mining | PubMed |
| Retraction: Long non-coding RNA TUG1 promotes cervical cancer progression by regulating the miR-138-5p-SIRT1 axis. | Oncotarget | 2025 | 42664418 | PubTator, text mining | PubMed |
| Overview of exosomal non-coding RNAs in cardiovascular disease using high throughput sequencing. | Eur J Pharmacol | 2025 | 42640698 | PubTator, text mining | PubMed |
| TUG1: a potential endogenous reference gene for long noncoding RNA quantification in blood-based studies. | Biomark Res | 2025 | 41469728 | PubTator, text mining | PubMed |
| Overexpression of the lncRNA TUG1 regulates high-glucose-induced endocytic clearance dysfunction in HLSECs via the Wnt/β-catenin signaling pathway. | Eur J Med Res | 2025 | 41454418 | PubTator, text mining | PubMed |
| Long Non-Coding RNAs in Multiple Sclerosis-Differential Expression and Functional Implications. | Genes (Basel) | 2025 | 41300779 | PubTator, text mining | PubMed |
| The potential role of BM-MSC-derived exosomes in TUG1 modulation: antileukemic effects on THP-1 cells. | Med Oncol | 2025 | 41212348 | PubTator, text mining | PubMed |
| Targeting SRPK1 to regulate alternative splicing in prostate cancer: the roles of MALAT1 and TUG1. | Mol Biol Rep | 2025 | 41196435 | PubTator, text mining | PubMed |
| Emerging in Diabetic Cardiomyopathy: Molecular Pathways and Targets for Therapeutic Intervention. | Drug Dev Res | 2025 | 41183131 | PubTator, text mining | PubMed |
| Editorial: Fecal Microbiota Transplants: challenges in translating microbiome research to clinical applications. | Front Microbiol | 2025 | 41140403 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55000/papers?page=3